MX2009007792A - Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety. - Google Patents

Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety.

Info

Publication number
MX2009007792A
MX2009007792A MX2009007792A MX2009007792A MX2009007792A MX 2009007792 A MX2009007792 A MX 2009007792A MX 2009007792 A MX2009007792 A MX 2009007792A MX 2009007792 A MX2009007792 A MX 2009007792A MX 2009007792 A MX2009007792 A MX 2009007792A
Authority
MX
Mexico
Prior art keywords
extract
compositions
obtaining
pharmaceutical
dry extract
Prior art date
Application number
MX2009007792A
Other languages
Spanish (es)
Inventor
Jaime Tortoriello Garcia
Armando Herrera Arellano
Alejandro Zamilpa Alvarez
Maira Estrella Huerta Reyes
Jesus Enrique Jimenez Ferrer
Maribel Lucila Herrera Ruiz
Manases Gonzalez Cortazar
Original Assignee
Jaime Tortoriello Garcia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/MX2007/000135 external-priority patent/WO2009064151A1/en
Application filed by Jaime Tortoriello Garcia filed Critical Jaime Tortoriello Garcia
Priority to MX2009007792A priority Critical patent/MX2009007792A/en
Publication of MX2009007792A publication Critical patent/MX2009007792A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to pharmaceutical formulations comprising a dry extract of <i>Galphimia glauca</i> for treating anxiety, in which the active agents are compounds known as galphimines A, B and E. The method of obtaining said extract significantly increases the concentration of the active principles (concentration of up to 50 times greater than with previous methods), resulting in a greater anxiolytic effect and enabling pharmaceutical presentation forms which are smaller than those proposed in the prior art, by capsule or coated tablet, which are more effective and user-friendly for patients. The pharmaceutical formulation to which the invention relates has a better anxiolytic effect than extracts disclosed in the prior art, without the side effects of the drugs currently used in anxiety treatments.
MX2009007792A 2007-11-12 2009-07-22 Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety. MX2009007792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2009007792A MX2009007792A (en) 2007-11-12 2009-07-22 Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/MX2007/000135 WO2009064151A1 (en) 2007-11-12 2007-11-12 Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety
MX2009007792A MX2009007792A (en) 2007-11-12 2009-07-22 Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety.

Publications (1)

Publication Number Publication Date
MX2009007792A true MX2009007792A (en) 2009-07-31

Family

ID=41559030

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007792A MX2009007792A (en) 2007-11-12 2009-07-22 Method of obtaining a dry extract of galphimia glauca, pharmaceutical compositions comprising said extract and use of the compositions to treat anxiety.

Country Status (1)

Country Link
MX (1) MX2009007792A (en)

Similar Documents

Publication Publication Date Title
IN2015DN00376A (en)
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
MA33044B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, ITS GALENIC DOSAGE FORM, PREPARATION METHOD AND USES FOR ENHANCED GLYCEMIC REGULATION IN PATIENT
EA200870393A1 (en) NEW COMPOSITIONS FOR HAIR VIOLATIONS AND METHOD FOR OBTAINING COMPOSITIONS
MX344787B (en) Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders.
MY156316A (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
TN2011000437A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
NO20080284L (en) Cannabionoid active pharmaceutical ingredient for improved dosage forms
NO20100301L (en) Improved brimonidine compositions for the treatment of erythema
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
MY143795A (en) Tetrahydropyridoindole derivatives
AR079552A1 (en) METHOD FOR THE TREATMENT OF ATRIAL FIBRILATION. PHARMACEUTICAL FORMULATION
MX344476B (en) Methods of treating pulmonary disorders with liposomal amikacin formulations.
IN2014MN00139A (en)
WO2013183062A3 (en) Palatable formulations of ibuprofen
SA113340494B1 (en) Composition for treating metabolic disorders
WO2011051633A3 (en) Use of a punica granatum extract to fight against the whitening of the hair
WO2010028173A3 (en) Method of treating atrial fibrillation
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
MX2012002681A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units.
UA112418C2 (en) THERAPEUTIC DISEASE
EA201200754A1 (en) TRADITIONAL CHINESE DRUG, CONTAINING DAN-SHEN EXTRACTS (DANSHEN) AND SAN-KI (SANQI), AND ITS APPLICATION
MX391191B (en) EXTENDED-RELEASE COMPOSITIONS OF ONAPRISTONE AND METHODS.
MX2009012712A (en) Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.
CY1111361T1 (en) NEW DESIGNS RAR RECEPTORS ASSOCIATES, USE IN HUMAN MEDICAL AND IN COSMETOLOGY

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights